CD3 T cells were not associated with OS in the patients who are ER+ with breast cancer (FDR = 0.12, n = 162); however, in tumors with proliferation above the median, increased CD3 T cells were associated with longer OS (FDR = 0.0028, n = 74) (Figure 3E). This evidence concerns the gene ESR1 and breast cancer.